Feldman-Stewart D, Brundage MD, Hayter C, et al What questions do patients with curable prostate cancer want answered ?Med Decis Making.2000;207-19.
2.
Mazur DJ.Information disclosure and beyond: how do patients understand and use the information they report they want?Med Decis Making2000;20:132-4
3.
Kassirer JP.Our stubborn quest for diagnostic certainty; a cause of excessive testing. N Engl J Med.1989;320:1489-91
4.
Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG.Early detection of prostate cancer. II. Estimating the risks, benefits, and costs: American College of PhysiciansAnn Intern Med1997,126:468-79
5.
Chang PL, Yu-Chuan L, Wang TM, Huang ST, Hsieh ML, Tsui KH.Evaluation of a decision-support system for preoperative staging of prostate cancerMed Decis Making1999;19419-27.
6.
D'Amico AV, Whittington R, Schnall M, et al. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer. Cancer. 1995;75:2368-72.
7.
Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerJ Urol.1993;150:110-4
Jager GJSeverens JL, Thornbury JR, de la Rosette JJMCH, Ruijs SHJ, Barentsz JO.Prostate cancer staging: should MR imaging be used?A decision analytic approach Radiology2000;215:445-51
10.
Feldman-Stewart D, Brundage MD, Hayter C, et al. What prostate cancer patients should know: variations in professionals' opinions . Radiother Oncol1998;49111-23
11.
McDonald CJ.Medical heuristics. the silent adjudicator of clinical practiceAnn Intern Med.1996;124:56-62